Citius Oncology (CTOR) vs Stablecoin Development (SDEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Citius Oncology (CTOR) has outperformed Stablecoin Development (SDEV) over the past year, losing 54.6% versus a loss of 66.8%. Citius Oncology is the larger company by market cap ($88.5 million vs $85.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTOR | SDEV |
|---|---|---|
| Share price | $0.8364 | $1.66 |
| Market cap | $88.46M | $85.65M |
| 1-day change | +0.17% | -16.83% |
| YTD return | -16.50% | -92.94% |
| 1-year return | -54.62% | -66.83% |
| 5-year return | — | -99.94% |
| EPS (TTM) | $-0.48 | $-21.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.25 | $99.75 |
| 52-week low | $0.491 | $0.78 |
| Distance from 52-week high | -62.83% | -98.34% |
| Analyst consensus | none | — |
| Avg. price target upside | +378.24% | — |
| Average volume | 100.32K | 11.74M |
| Shares outstanding | 105.76M | 51.75M |
| Employees | — | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CTOR has outperformed SDEV by 12.2 percentage points over the past year.
About Citius Oncology
CTOR stock →Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies.
Health Care · Biotechnology: Pharmaceutical Preparations
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
CTOR vs SDEV FAQ
Which is bigger, Citius Oncology or Stablecoin Development?
Citius Oncology (CTOR) is larger, with a market capitalization of $88.46M compared with $85.65M for Stablecoin Development (SDEV).
Which stock has performed better over the past year, CTOR or SDEV?
CTOR returned -54.62% over the past 12 months, compared with -66.83% for SDEV (price return, excluding dividends). Past performance does not predict future results.
Are Citius Oncology and Stablecoin Development in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.